Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The WEE1 homolog pseudogene, designated as ENSG00000264431, is a genomic sequence related to the WEE1 kinase gene, but it does not encode a functional protein. Unlike the canonical WEE1 kinase, which is a serine/threonine protein kinase regulating the cell cycle and is an established therapeutic target in oncology, pseudogenes like ENSG00000264431 have lost their protein-coding ability and generally have no direct biological function. The therapeutic relevance, disease role, and drug interactions pertain to the active WEE1 kinase rather than this pseudogene[2][3][6]. If structured information about an active target is required, refer to the canonical WEE1 kinase gene (e.g., ENSG00000117215), not to the pseudogene ENSG00000264431.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WEE1 homolog pseudogene (null).